← brief for 2026-08-13 · Slowing decline

Renal Volume Reduction on Magnetic Resonance Imaging During Tolvaptan Therapy in Patients with ADPKD: A Case Series.

Key takeaways

Four patients with polycystic kidney disease (PKD) showed stable kidney volume over 12 months of tolvapran therapy. This case series shows no reduction in kidney volume despite drug use.

Who did this work

Koçyiğit İ (Department of Nephrology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.) · Aydın E (Department of Nephrology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey.) · Baloğlu İ (Department of Nephrology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.) · Kılıç K (Department of Nephrology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.) · Demiray A (Department of Nephrology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.)

Source

Paper · Europe PMC, CKD · 2026-08-11
https://doi.org/10.1093/joneph/aajag218